Lin Yang
Impact in
- Nephrology top 2%
- Acute Kidney Injury Research
- Chronic Kidney Disease and Diabetes
-
- Acupuncture Treatment Research Studies
Papers in
- Hepatology 10
- Liver physiology and pathology 10
- Oncology 17
- Drug Transport and Resistance Mechanisms 8
- Cancer Treatment and Pharmacology 4
- Co-authors
- Liying Li (16 shared papers)Le Yang (9 shared papers)Na Chang (7 shared papers)Weiyang Li (6 shared papers)Xianfei Ji (5 shared papers)Lei Tian (4 shared papers)Changyong Li (2 shared papers)Aidong Wen (13 shared papers)
- Journals
- Journal of Molecular Medicine (3 papers)Frontiers in Pharmacology (3 papers)Clinical Therapeutics (3 papers)British Journal of Clinical Pharmacology (2 papers)Resuscitation (2 papers)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Lin Yang
116 papers receiving 2.2k citations
Lin Yang's Hit Papers
Peers
Comparison fields: 5 of 118
- Nephrology 329
- Complementary and alternative medicine 169
- Transplantation 43
- Hepatology 108
- Emergency Medicine 116
Countries citing papers authored by Lin Yang
This map shows the geographic impact of Lin Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Yang more than expected).
Fields of papers citing papers by Lin Yang
This network shows the impact of papers produced by Lin Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Yang. The network helps show where Lin Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 125 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Acute kidney injury in China: a cross-sectional survey Hit paper breakdown → | 2015 | 384 |
| 2 | 2008 | 126 | |
| 3 | 2017 | 90 | |
| 4 | 2009 | 89 | |
| 5 | 2012 | 84 | |
| 6 | 2011 | 70 | |
| 7 | 2016 | 57 | |
| 8 | 2018 | 55 | |
| 9 | 2011 | 54 | |
| 10 | 2017 | 50 | |
| 11 | 2023 | 50 | |
| 12 | 2010 | 47 | |
| 13 | 2007 | 45 | |
| 14 | 2008 | 43 | |
| 15 | 2020 | 38 | |
| 16 | 2020 | 35 | |
| 17 | 2023 | 34 | |
| 18 | 2020 | 34 | |
| 19 | 2017 | 33 | |
| 20 | 2016 | 31 |
About Lin Yang
Lin Yang is a scholar working on Hepatology, Oncology, Pharmacology, Immunology and Molecular Biology, having authored 125 papers that have together received 2.2k indexed citations. Recurring topics across this work include Liver physiology and pathology (10 papers), Drug Transport and Resistance Mechanisms (8 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers), Immune cells in cancer (6 papers), Analytical Methods in Pharmaceuticals (5 papers), Cancer Treatment and Pharmacology (4 papers), Pancreatic function and diabetes (4 papers) and Sphingolipid Metabolism and Signaling (4 papers). The work is most often cited by research in Nephrology (329 citations), Complementary and alternative medicine (169 citations), Transplantation (43 citations), Hepatology (108 citations) and Emergency Medicine (116 citations). Lin Yang has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Liying Li, Le Yang, Na Chang, Weiyang Li, Xianfei Ji, Lei Tian, Changyong Li, Aidong Wen, Chunsheng Li and Xiaofang Ji. Their work appears in journals such as Journal of Molecular Medicine, Frontiers in Pharmacology, Clinical Therapeutics, British Journal of Clinical Pharmacology and Resuscitation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.